The number of people with susceptibility test result for rifampicin in Nepal
Nepal: The number of people with susceptibility test result for rifampicin was 11,863 in 2021. ◆ Volatile
Latest (2021)
11,863
Change on year
up 45.8%
World rank
19th
of 155 countries
All-time high
12,853
in 2019
All-time low
192
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Nepal, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Nepal is 11,863, measured in 2021.
That represents a change of up 45.8% on the previous year and up 6,078.6% over five years.
That places Nepal 19th out of 155 countries with data for 2021, putting it in the top quarter.
The number of people with susceptibility test result for rifampicin in Nepal, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 192 | — |
| 2018 | 7,821 | +3973.4% |
| 2019 | 12,853 | +64.3% |
| 2020 | 8,135 | -36.7% |
| 2021 | 11,863 | +45.8% |
Nepal compared with similar countries
- Nepal's 11,863 is above the median for lower middle income countries, which is 2,804, 4.2× the median. (32 countries reporting)
- Nepal's 11,863 is above the median for South Asia, which is 11,863, 1.0× the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 6,955 | 192 | 12,853 | 3 |
| 2020s | 9,999 | 8,135 | 11,863 | 2 |
Countries ranked near Nepal
More health data for Nepal
- Un projection of annual infant deaths, annual growth rate -1.95 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8518 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,326 deaths per 1,000 people (2090)
- Number of infants who die before age 1 955 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate -1.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0451 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Nepal?
- The number of people with susceptibility test result for rifampicin in Nepal was 11,863 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Nepal?
- The highest recorded value was 12,853 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Nepal?
- The lowest recorded value was 192 in 2017.
- How does Nepal rank for the number of people with susceptibility test result for rifampicin?
- Nepal ranks 19th out of 155 countries with data for 2021.
- Where does this Nepal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).